Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
Healthy Volunteers
Bottom Line
View on ClinicalTrials.gov: NCT00706381 ↗Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Sincalide (Drug); Ursodiol (Drug); Fat Meal (Procedure); Carb meal (Procedure); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Primary completion
- Aug 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Energy Expenditure |
1.37; 1.40; 1.28; 1.27; 1.28 | 0.0001 sig |
| PRIMARY Bile Acid |
2.89; 7.26; 2.42; 5.17; 2.69 | 0.096 |
Summary
Eligibility Criteria
- INCLUSION CRITERIA:
Age greater than or equal to18 years, male or female
Written informed consent
EXCLUSION CRITERIA
Hypo- or hyperthyroidism (history or serum thyroid-stimulating hormone (TSH) greater than 5.0 or less than 0.4 miU/L)
Blood pressure greater than 140/90 mmHg (26) or receiving antihypertensive therapy
History of cardiovascular disease
BMI less than or equal to 20 or greater than or equal to 27 Kg/m(2)
Diabetes mellitus (fasting serum glucose greater than or equal to 126 mg/dL)
Hyperlipidemia (serum total cholesterol greater than or equal to 240 mg/dL, triglycerides greater than or equal to 220 mg/dL, and/or use of antilipemic therapy)
Liver disease or ALT serum concentrations greater than 1.5 times the upper laboratory reference limit
Hyperbilirubinemia (serum total bilirubin greater than 1.5 mg/dL)
Renal insufficiency or estimated creatinine clearance less than or equal to 50 mL/min (MDRD equation)
Anemia (Hemoglobin concentration less than or equal to 11.1 g/dL females, and 12.7 g/dL males)
History of cholecystectomy or cholelithiasis (by ultrasound at screening).
History of malabsorption, or food allergies/intolerances that would preclude participant from consuming foods required for study
Claustrophobia
History of illicit drug or alcohol abuse within the last 5 years; current use of illicit drugs (by history) or alcohol (CAGE greater than 3)
Psychiatric conditions or behavior that would be incompatible with safe and successful participation in this study
Current use of medications/dietary supplements/alternative therapies known to alter thyroid function, energy expenditure or bile acid secretion
History of weight loss or weight gain of greater than 3 percent body weight over the past 2 months (self-reported)
Pregnancy/breastfeeding/hormonal contraceptive use and childbirth within the last 6 months
Perimenopausal (as self-described within two years from onset of amenorrhea or current complaints of hot flashes)
Current smoker
Data sourced from ClinicalTrials.gov (NCT00706381). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.